Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-30T16:38:53.190Z Has data issue: false hasContentIssue false

COVID-19: A Chimera of Two Pandemics

Published online by Cambridge University Press:  25 June 2020

Parnian Jabbari
Affiliation:
Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
Forouq Jabbari
Affiliation:
Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran
Saied Ebrahimi
Affiliation:
Research Department of Rajaei Heart Center, Iran University of Medical Sciences, Tehran, Iran
Nima Rezaei*
Affiliation:
Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
*
Correspondence and reprint requests to Nima Rezaei, Research Center for Immunodeficiencies, Children’s Medical Center Hospital, Dr Qarib St, Keshavrz Blvd, 14194Tehran, Iran (e-mail: rezaei_nima@yahoo.com).
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 2020 Society for Disaster Medicine and Public Health, Inc.

The first cases of coronavirus disease (COVID-19) were observed in China in late 2019 and developed to a pandemic in a matter of weeks due to high rates of person-to-person transmission. Reference Hanaei and Rezaei1,Reference Shereen, Khan and Kazmi2 Public authorities soon responded to the crisis by placing stay-in-shelter orders. Although effective in reducing the transmissions, the challenges posed by these rules urged their termination. As individuals are re-engaging in social activities, given that an effective vaccine may not be available before 2021 Reference Thanh Le, Andreadakis and Kumar3 makes us rely on slowing person-to-person transmission to control this pandemic. Although due to similar routes of transmission, we often refer to the H1N1 pandemic of 1918 to model how COVID-19 will evolve, we believe that the still ongoing HIV/AIDS pandemic can inspire us in 3 main ways to fight the COVID-19 pandemic in a similar way that the HIV/AIDS pandemic was controlled, despite growing globalization.

ADDRESSING HIGH-RISK GROUPS

In early stages of the HIV/AIDS pandemic, intravenous drug users and individuals with high-risk sexual activity were noted to be high-risk. Reference Camacho-Gonzalez, Wallins and Toledo4 Global organizations emphasized on the importance of destigmatization, acknowledging individuals’ choices, and breaking the vicious cycle of discrimination leading to the susceptibility for the disease and the disease being a source of discrimination. Reference Camacho-Gonzalez, Wallins and Toledo4

In the case of COVID-19, the elderly and those with comorbidities are high-risk and advised to self-isolate. Apart from the psychological effects, Reference Camacho-Gonzalez, Wallins and Toledo4 such restrictions are in contrast with enabling individuals’ choices. Authorities need to provide guidelines for communities to enable social involvement of high-risk individuals while providing them with a safe environment.

EDUCATIONAL MEASURES

A safe environment in terms of contracting COVID-19 cannot be achieved unless every individual is well educated on preventive measures. Current guidelines emphasize on physical distancing, hand-hygiene, and the use of personal protective equipment (PPE) to slow person-to-person transmission. Reference Camacho-Gonzalez, Wallins and Toledo4 Thus far, the emphasis of countries has been on providing more testing and reports on mass education of preventive measures, and monitoring adherence to these guidelines are sparse, if any.

Education is shown to be a key factor in bringing the HIV/AIDS pandemic under control. Although the long timeframe for HIV made much of this education possible, we can still rely on the effectiveness of these methods by using mass media and interactive educational programs. Reference Faust and Yaya5

ELIMINATING HEALTH INEQUALITIES

Although HIV/AIDS was first spread among well-connected networks, many factors, including discrimination and marginalization, shifted the burden of the disease on less privileged parts of the society. Reference Camacho-Gonzalez, Wallins and Toledo4 This led to worldwide attempts to provide high-risk groups with protection equipment such as condoms, clean needles, and free access to antiretroviral therapy.

In the COVID-19 pandemic, these risk factors translate to lack of access to soap and clean water and the inability to social distance due to low socioeconomic status and living conditions. These are effective and cheap tools to control the spread of many infectious diseases, including COVID-19. High transmission rates of the disease warrant calls for global action to provide PPE to all social groups indiscriminately. Reference Shereen, Khan and Kazmi2 These measures can help bring under control COVID-19 – a pandemic chimera of the HIV/AIDS and H1N1 pandemics.

Conflict of Interest Statement

The authors have no conflicts of interest to declare.

References

REFERENCES

Hanaei, S, Rezaei, N. COVID-19: developing from an outbreak to a pandemic. Arch Med Res. 2020;epub, doi: 10.1016/j.arcmed.2020.04.021.CrossRefGoogle ScholarPubMed
Shereen, MA, Khan, S, Kazmi, A, et al. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:9198.CrossRefGoogle ScholarPubMed
Thanh Le, T, Andreadakis, Z, Kumar, A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305306.CrossRefGoogle ScholarPubMed
Camacho-Gonzalez, AF, Wallins, A, Toledo, L, et al. Risk factors for HIV transmission and barriers to HIV disclosure: metropolitan Atlanta youth perspectives. AIDS Patient Care STDS. 2016;30(1):1824.CrossRefGoogle ScholarPubMed
Faust, L, Yaya, S. The effect of HIV educational interventions on HIV-related knowledge, condom use, and HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2018;18(1):1254.10.1186/s12889-018-6178-yCrossRefGoogle ScholarPubMed